BTAI Competitors & Alternatives

Compare BioXcel Therapeutics Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

BTAI

Main Stock
$0.90
Tradestie Score
43
Market Cap
$50.49M
Revenue Growth
0.2%
Analyst Upside
+1460.2%

Top Competitors

48 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
CRON Cronos Group Inc. Common Share
$3.15
$1.02B 16.6 38 Compare
AQST Aquestive Therapeutics, Inc. Common Stock
$4.29
$711.32M - 43 Compare
ESPR Esperion Therapeutics, Inc.
$3.18
$584.71M - 53 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$62.04
$543.32M - 44 Compare
EOLS Evolus, Inc. Common Stock
$8.20
$397.82M - 25 Compare
ALLO Allogene Therapeutics, Inc. Common Stock
$2.07
$275.13M - 36 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$4.34
$237.15M 5.5 48 Compare
ATRA Atara Biotherapeutics, Inc
$8.18
$101.48M - 55 Compare
KPTI Karyopharm Therapeutics Inc.
$1.96
$53.85M - 60 Compare
KYNB KYNB
$7.06
- - 47 Compare

Data updated: Aug 17, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

48 stocks in this industry